YD Bio Limited (YDES)

YD Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	3.13	0.09	0.03
Cash & Short-Term Investments	3.13	0.09	0.03
Cash Growth	3496.29%	188.96%	-
Accounts Receivable	0.1	0.1	0.04
Other Receivables	0.16	0	0
Receivables	0.26	0.1	0.04
Inventory	0.04	0.07	0.04
Prepaid Expenses	0.03	0	0
Other Current Assets	0.01	0.01	0.02
Total Current Assets	3.47	0.27	0.13
Property, Plant & Equipment	0.09	0.01	0.06
Long-Term Investments	-	0.01	0.01
Other Intangible Assets	2.68	-	-
Long-Term Deferred Tax Assets	-	0.02	0.03
Long-Term Deferred Charges	0.63	-	-
Total Assets	6.86	0.32	0.23
Accounts Payable	0.03	0.02	0.01
Accrued Expenses	0.22	0.02	0.01
Current Portion of Long-Term Debt	-	0.03	0.03
Current Portion of Leases	0.02	0.01	0.04
Other Current Liabilities	-	0.22	0.07
Total Current Liabilities	0.26	0.3	0.17
Long-Term Debt	-	-	0.04
Long-Term Leases	0.01	-	0.01
Long-Term Deferred Tax Liabilities	0	-	-
Other Long-Term Liabilities	0	-	-
Total Liabilities	0.27	0.3	0.22
Common Stock	0.14	0.11	0.11
Additional Paid-In Capital	8.33	0.39	0.39
Retained Earnings	-1.93	-0.52	-0.53
Comprehensive Income & Other	0.05	0.05	0.05
Shareholders' Equity	6.59	0.02	0.01
Total Liabilities & Equity	6.86	0.32	0.23
Total Debt	0.02	0.05	0.12
Net Cash (Debt)	3.11	0.04	-0.09
Net Cash Growth	7769.12%	-	-
Net Cash Per Share	2.84	0.04	-
Filing Date Shares Outstanding	1.44	1.05	-
Total Common Shares Outstanding	1.44	1.05	-
Working Capital	3.2	-0.03	-0.04
Book Value Per Share	4.57	0.02	-
Tangible Book Value	3.91	0.02	0.01
Tangible Book Value Per Share	2.71	0.02	-
Machinery	0.08	0.01	0.04
Leasehold Improvements	-	-	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q